Filter
98
Text search:
Lopinavir/Ritonavir
Featured
Recommendations
24
New Publications
27
Language
Document type
No document type
46
Guidelines
32
Fact sheets
9
Studies & Reports
7
Manuals
2
Training Material
1
Infographics
1
Countries / Regions
Ethiopia
3
India
3
Germany
3
Malawi
3
Russia
3
Burkina Faso
2
Nigeria
2
Ghana
2
Uganda
2
Nepal
2
Tanzania
2
Namibia
2
Madagascar
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Paraguay
2
France
2
Spain
2
Sierra Leone
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Niger
1
Togo
1
Haiti
1
Zambia
1
Turkey
1
Kenya
1
Thailand
1
Rwanda
1
South Africa
1
Mozambique
1
Benin
1
Central African Republic
1
Peru
1
Burundi
1
Ecuador
1
Angola
1
Myanmar / Burma
1
Latin America and the Carribbean
1
Luxembourg
1
Venezuela
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Global
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
49
Clinical Guidelines
8
Pharmacy & Technologies
3
Women & Child Health
2
Key Resources
1
Toolboxes
COVID-19
28
HIV
21
Pharmacy
12
TB
3
Ebola & Marburg
1
Mental Health
1
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
CDC Afrique est préoccupé par les informations inexactes distribués par les médias traditionnels et sociaux en ce qui concerne la prévention et le traitement des maladies nouvelles coronavirus (Covid-19).
Sur la base d’un examen des preuves et de l’évaluation d’experts, le CDC Afrique r
...
Nirmatrelvir-ritonavir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The Africa Centres for Disease Control and Prevention (Africa CDC) is concerned about inaccurate information being distributed through traditional and social media regarding prevention and treatment of novel coronavirus disease (COVID-19).
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I
...
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной
...
Manuel pour les personnels impliqués dans la prise en charge pédiatrique du VIH
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
Option B+
20 Mart 2020
http://www.covid19-druginteractions.org
Çeviren:
Kamu Hastaneleri Genel Müdürlüğü
Tedarik Planlama, Stok ve Lojistik Yönetimi Daire Başkanlığı Hastane Eczacılığı Yönetim Birimi
